Kala Pharmaceuticals, Inc.
(NASDAQ : KALA)

( )
KALA After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Bitcoin & Crypto Movers
Receive our Bitcoin / Cryptocurrency Reports, Free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Major
symbolcompany%chnglast%shortavg$volume
JNJJohnson & Johnson
-0.35%139.010.6%$926.15m
PFEPfizer Inc.
1.11%44.490.9%$924.68m
MRKMerck & Co., Inc.
0.15%72.320.6%$639.05m
LLYEli Lilly and Company
-1.25%111.891.0%$524.94m
ABBVAbbVie, Inc.
-2.13%87.992.2%$445.82m
BMYBristol-Myers Squibb Company
-2.98%54.311.4%$381.19m
NVSNovartis AG Sponsored ADR
1.09%87.180.2%$204.52m
AZNAstraZeneca PLC Sponsored ADR
0.64%39.201.3%$161.21m
GSKGlaxoSmithKline plc Sponsored ADR
3.16%40.860.2%$92.30m
NVONovo Nordisk A/S Sponsored ADR Class B
-0.44%43.170.1%$88.68m
SNYSanofi Sponsored ADR
0.27%44.570.2%$60.88m
LCILannett Company, Inc.
-0.39%3.8637.0%$6.41m
AKTXAkari Therapeutics Plc Sponsored ADR
3.23%1.921.7%$0.17m
EPIXESSA Pharma Inc
-1.43%3.170.1%$0.03m

Company Profile

Kala Pharmaceuticals, Inc. is a biopharmaceutical company, focused on the development and commercialization of therapeutics using proprietary nanoparticle-based Mucus Penetrating Particles, or MPP, technology, with an initial focus on the treatment of eye diseases. The company was founded by Justin Hanes, Robert S. Langer and Colin R. Gardner in 2009 and is headquartered in Waltham, MA.